+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dacarbazine"

Malignant Melanoma Treatment Global Market Report 2024 - Product Thumbnail Image

Malignant Melanoma Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
TEMODAR Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

TEMODAR Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
From
  • 5 Results (Page 1 of 1)
Loading Indicator

Dacarbazine is a chemotherapy drug used to treat certain types of lymphoma, a type of cancer that affects the lymphatic system. It is a nitrogen mustard alkylating agent, meaning it works by damaging the DNA of cancer cells, preventing them from growing and dividing. Dacarbazine is typically used in combination with other drugs, such as bleomycin, vinblastine, and doxorubicin, to increase its effectiveness. It is usually administered intravenously, but can also be taken orally. Dacarbazine is a widely used drug for the treatment of lymphoma, and is available in both generic and branded forms. It is typically prescribed as a first-line treatment for Hodgkin's lymphoma, and is also used to treat other types of lymphoma, such as non-Hodgkin's lymphoma and cutaneous T-cell lymphoma. Several companies manufacture and market dacarbazine, including Bristol-Myers Squibb, Teva Pharmaceuticals, and Mylan. Other companies, such as Hospira and Baxter, produce generic versions of the drug. Show Less Read more